Related Experiment Videos
Are contemporary methods for somatic gene therapy suitable for clinical applications?
1Howard Hughes Medical Institute, Department of Cell Biology, Baylor College of Medicine, Houston, Texas.
Summary
Somatic gene therapy clinical trials, initiated in 1989, have demonstrated safety and public acceptance. Early trials focused on lymphocytes for cancer and immunodeficiency, with ongoing studies in other tissues, showing feasibility for human gene transfer.
Area of Science:
- Biotechnology
- Medical Genetics
- Immunology
Background:
- Somatic gene therapy involves introducing recombinant genes into human cells.
- Ethical and technical debates preceded the first clinical trials in 1989.
- Initial trials targeted peripheral blood lymphocytes.
Purpose of the Study:
- Review basic methods for somatic gene therapy.
- Analyze proposed and performed clinical trials.
- Assess the safety and feasibility of gene transfer in humans.
Main Methods:
- Introduction of recombinant genes into peripheral blood lymphocytes.
- Gene transfer into bone marrow, hepatocytes, and tumor cells in ongoing trials.
- Review of existing clinical trial data.
Main Results:
- Gene therapy can be safely administered in select clinical trials.
- Public acceptance has been observed for gene therapy trials.
- Clinical trials provide essential data on gene transfer feasibility and safety.
Conclusions:
- Existing somatic gene therapy methods are suitable for current clinical trials.
- Clinical experience supports the safe application of gene therapy.
- Further advancements in somatic gene therapy are anticipated.